The 17 references in paper E. Biryukova V., V. Ignat’eva I., Е. Бирюкова В., В. Игнатьева И. (2017) “Старт и интенсификация инсулинотерапии у пациентов с сахарным диабетом 2-го типа: анализ влияния на бюджет // Initiation and intensification of insulin therapy in patients with type 2 diabetes mellitus: a budget impact analysis” / spz:neicon:pharmacoeconomics:y:2017:i:3:p:3-10

1
Standards of medical care in diabetes – 2017. Diabetes Care.
(check this in PDF content)
2
17; 40 (1): 1-142. 2. Giugliano D., Sieradzki J., Stefanski A., Gentilella R. Personalized intensification of insulin therapy in type 2 diabetes – does a basal-bolus regimen suit all patients? Curr Med Res Opin. 2016; 32 (8): 1425-34.
(check this in PDF content)
3
Turner H. E., Matthews D. R. The use of fixed-mixture insulins in clinical practice. Eur J Clin Pharmacol. 2000; 56 (1): 19-25.
(check this in PDF content)
4
Maiorino M. I., Bellastella G., Esposito K., Giugliano D. Premixed insulin regimens in type 2 diabetes. Pros. Endocrine. 2017; 55 (1): 45-50.
(check this in PDF content)
5
Chazova T. Russkii meditsinskii zhurnal (in Russian). 2003; 11 (27): 15-20.
(check this in PDF content)
6
Kalashnikova M. F., Belousov D. Yu., Suntsov Yu. I., Kantemirova M. A., Dedov I. I. Sakharnyi diabet (in Russian). 2015; 18 (2): 32-46.
(check this in PDF content)
7
Algorithms of specialized medical care for patients with diabetes mellitus. Ed. I. I. Dedova, M. V. Shestakova, A. Yu. Mayorova. The 8th issue [Algoritmy spetsializirovannoi meditsinskoi pomoshchi bol’nym sakharnym diabetom. Pod red. I. I. Dedova, M. V. Shestakovoi, A. Yu. Maiorova. 8-i vypusk (in Russian)]. Moscow. 2017; 112 s.
(check this in PDF content)
8
Buse J. B., Wolffenbuttel B. H., Herman W. H., Shemonsky N. K., Jiang H. H., Fahrbach J. L., Scism-Bacon J. L., Martin S. A. DURAbility of basal versus lispro mix 75/25 insulin efficacy (DURABLE) trial 24-week results: safety and efficacy of insulin lispro mix 75/25 versus insulin glargine added to oral antihyperglycemic drugs in patients with type 2 diabetes. Diabetes Care. 2009; 32 (6): 1007-13.
(check this in PDF content)
9
Miser W. F., Arakaki R., Jiang H., Scism-Bacon J., Anderson P. W., Fahrbach J. L. Randomized, open-label, parallel-group evaluations of basal-bolus therapy versus insulin lispro premixed therapy in patients with type 2 diabetes mellitus failing to achieve control with starter insulin treatment and continuing oral antihyperglycemic drugs: a noninferiority intensification substudy of the DURABLE trial. Clin Ther. 2010; 32 (5): 896-908.
(check this in PDF content)
10
Dedov I. I., Omel’yanovskii V. V., Shestakova M. V., Avksent’eva M. V., Ignat’eva V. I. Sakharnyi diabet (in Russian). 2016; 19 (1): 30-43.
(check this in PDF content)
11
Type 2 diabetes in adults: management (NG28). NICE guideline. URL: nice.org.uk/guidance/ng28. Accessed: 25.05.2017.
(check this in PDF content)
12
Swinnen S. G., Simon A. C., Holleman F., Hoekstra J. B., Devries J. H. Insulin detemir versus insulin glargine for type 2 diabetes mellitus. Cochrane Database Syst Rev. 2011.10.1002/14651858. CD006383.pub2 No 7. C. CD006383.
(check this in PDF content)
13
Lasserson D. S., Glasziou P., Perera R., Holman R. R., Farmer A. J. Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses. Diabetologia. 2009; 52 (10): 1990-2000.
(check this in PDF content)
14
Rys P., Wojciechowski P., Siejka S., Malecki P., Hak L., Malecki M. T. A comparison of biphasic insulin aspart and insulin glargine administered with oral antidiabetic drugs in type 2 diabetes mellitus – a systematic review and meta-analysis. Int J Clin Pract. 2014; 68 (3): 304-13.
(check this in PDF content)
15
Wang C., Mamza J., Idris I. Biphasic vs basal bolus insulin regimen in Type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabet Med. 2015; 32 (5): 585-94.
(check this in PDF content)
16
Giugliano D., Chiodini P., Maiorino M. I., Bellastella G., Esposito K. Intensification of insulin therapy with basal-bolus or premixed insulin regimens in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Endocrine. 2016; 51 (3): 417-28.
(check this in PDF content)
17
Giugliano D., Maiorino M. I., Bellastella G., Chiodini P., Ceriello A., Esposito K. Efficacy of insulin analogs in achieving the hemoglobin A1c target of <7% in type 2 diabetes: metaanalysis of randomized controlled trials. Diabetes Care. 2011; 34 (2): 510-7.
(check this in PDF content)